(Q45408057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

Japanese encephalitis virus

24 December 2019

main subject

0 references

0 references

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

4

Kenneth H Eckels

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Arthur Lyons

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Niranjan Kanesa-thasan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert A Kuschner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert Putnak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Wellington Sun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert Burge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Andrew C Towle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Paul Wilson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

David W Vaughn

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

English

0 references

publication date

4 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

3445-3453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. IV. Vector studies

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Detection of west Nile and Japanese encephalitis viral genome sequences in cerebrospinal fluid from acute encephalitis cases in Karachi, Pakistan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

The epidemiology of Japanese encephalitis: prospects for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Protection against Japanese encephalitis by inactivated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Assay of arbovirus neutralizing antibody by micro methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Analyzing data from ordered categories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

Japanese B encephalitis in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.046

10.1016/J.VACCINE.2006.12.046

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17241714%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference